Ozempic and Wegovy have received a lot of publicity as revolutionizing treatment options for obesity. Both medications form a class of GLP-1 receptor agonists, which mimic a hormone in the body called glucagon-like peptide-1 and are involved in the regulation of appetite and blood sugar. Indeed, in initial clinical studies, the majority of those on the drugs lost 15% to 22% of body weight, hence much optimism. For most patients, these medications are underwhelming for about 20% of patients due to minimal weight loss or other challenges.

Take a closer look at why the weight loss drugs may not work for everyone, together with what options exist when they don't deliver the expected outcomes.

Why Weight Loss Drugs May Not Work

While GLP-1 receptor agonists have produced phenomenal responses in a majority of patients, it remains a reality that these drugs work differently for different people. Here's why:

1. Genetic and Hormonal Variability

Weight loss medications interact with complex systems in the body that differ from person to person. Genetics, hormones, and individual brain responses to energy regulation play significant roles in determining how a person responds to drugs like Ozempic and Wegovy.

2. Underlying Medical Conditions

Other conditions, such as sleep apnea, may be prevalent and prevent or delay the achievement of weight loss goals. Prescription drugs like antidepressants, steroids, or contraceptives are other medications that can nullify weight loss medication benefits.

3. Unrealistic Expectations

Often, they come to these medications with enormous hopes; expecting the promised rapid and dramatic weight loss. Progress creates disappointment if it has not stalled. In patients who rigidly follow recommended lifestyle modifications, frustration and disappointment are most common.

Why it is Important to Identify Non-responders

For most patients, the effectiveness of GLP-1 receptor agonists is evident within a few weeks of treatment. Weight loss typically begins within a few weeks of initiating therapy and tends to increase with dosage. However, some patients respond very little, if at all, despite strict adherence to their regimen.

For nonresponders, this can feel like a dead end. However, understanding the unique complexities of obesity is essential. This condition stems from brain dysfunction, and the pathways that contribute to weight regulation differ among individuals.

Alternative Treatment Options

When Ozempic or Wegovy doesn’t yield desired results, there are still many paths to explore:

1. Switching to Another GLP-1 Drug

For example, some patients who don't respond well to one GLP-1 receptor agonist might find success with another drug in the same class. Newer medications, such as Zepbound, target other hormone pathways and seem promising even for those not responsive to earlier drugs.

2. Use of Older Medications

While there is much to say about newer drugs, older treatments can still be useful and work for some patients. One can also seek the help of a medical provider specializing in obesity treatments in order to identify the best alternatives.

3. Lifestyle Changes

Diet, exercise, sleep, and stress management continue to be integral components of any weight loss program. New changes may be small but can make an enormous difference in one's health and success.

4. Medical Management of Obesity

It is a complex disorder, and most patients should receive a multidisciplinary treatment. Collaboration with an obesity-aware doctor may mean access to tailored treatment plans, ranging from psychological support all the way to metabolic testing, and many others.

Why Side Effects of Weight Loss Drug Ozempic May Be a Barrier

For others, side effects like nausea, vomiting, or diarrhea hinder them from continuing with these drugs. These symptoms often reduce as the body becomes accustomed, but for some, they might be severe enough to stop treatment altogether. In those instances, alternative drugs or procedures become vital to find.

Long-term effects of Ozempic or Wegovy on the Brain

Another largely unexplored area relates to GLP-1 drugs' long-term effects on the brain's regulation of hunger and satiety. Although GLP-1 drugs suppress appetite and can lead to effective weight loss, emerging research suggests that they may also affect brain reward mechanisms, changing the way patients experience foods.

This aspect could prove of paramount significance in the future treatment of obesity. Perhaps GLP-1 receptor agonists do indeed affect and rewire the brain's reward pathways and will thus provide sustained benefits beyond discontinuation. However, more research is required to understand this phenomenon fully.

While for many, Ozempic and Wegovy have revolutionized obesity treatment, these are certainly not a one size fits all. Nonresponders need not lose hope- alternative strategies and medications abound. A consultation with an obesity expert healthcare provider is essential to put together a comprehensive, tailored treatment plan.

The route toward effective weight loss may be challenging, but with the evolution of obesity medicine and a better understanding of individual needs, there is a path forward for everyone.

Did you know that prostate cancer is now the fastest-growing cancer among Indian men and yet remains one of the least discussed? Taking that first step to get tested for prostate cancer is the hardest thing a man will probably have to do. It is a delicate matter, no doubt, but lack of awareness and the stigma attached to the disease are keeping more and more men in the dark and hesitant to discuss this openly.

Indian men need to be nudged into taking that crucial first step towards treatment and to a healthy life waiting to be lived, post-treatment. The best way to break the societal stigma is to know everything about the disease and to demystify it.

Don’t forget, when it comes to getting the right medical aid for the disease, the second leading cause of death globally according to the WHO accounting for 10 million deaths since 2020, timing is everything. Thanks to all the technological advances made in the field in India and globally, there is hope for men across the world because prostate cancer is curable, provided it is detected early.

So, here is everything you need to know about it:

What Is Prostate Cancer?

The gland in the male reproductive system that makes seminal fluid is the prostate. This most common type of slow-growing cancer in men that sees the abnormal growth of cells in the gland, if detected early, is very much curable. Some early-stage symptoms of the disease are blood in the urine or semen, trouble urinating and erectile dysfunction and if you’re asking yourself, why you?

You could probably blame age, family history or lifestyle choices. While we cannot change the ‘why’, we can master the ‘how’ of finding the right treatment in time. Step 1: Rule out the possibility of cancer with a simple Prostate-Specific Antigen (PSA) blood test.

How Has Technology Increased The Success Rate Of Treatment?

In the last 10 years, technology and innovation have revolutionized the diagnostics and treatments of the disease. Scientists from across the world are working around the clock, making marked improvements in treating prostate cancer.

From surgery, radiation and hormone therapy to advanced AI-powered analytics, services and products, science ensures that the news gets better each day. We have AI analyzing vast quantities of medical data to find hidden patterns, and personalized prognoses, ensuring healthcare professionals are making diagnoses faster, more accurate and risk-free.

Similarly, minimally invasive treatments like TULSA-PRO are offering the medical fraternity and patients new hope. This incision and radiation-free, robotically-assisted and MRI-guided solution is a customizable treatment for prostate cancer. TULSA-PRO (Transurethral Ultrasound Ablation) uses real-time MRI guidance and ultrasound energy to precisely target and ablate prostate tissue without the need for incisions or radiation.

Patients can return to normal life in just a few days with faster recovery time and fewer side effects. This cutting-edge procedure uses MRI-guided transurethral ultrasound ablation (TULSA-PRO) to precisely destroy only the diseased tissue, whether it’s a small tumor (focal therapy) or the entire gland while actively cooling the urethra and rectum to protect them. It’s a one-time, day care, go home the same day with minimal pain and rapid return to normal life — most men resume work and normal activities within days.

While the science fraternity continues their path-breaking work in the field, it is also the responsibility of male citizens to keep themselves abreast of the developments in the field, report symptoms to a doctor early on, particularly those with a family history of prostate cancer.

Regular checkups are essential but so is knowing the difference between a routine check-up and specific tests for prostate cancer.

Former US Senator Ben Sasse is battling Stage 4 pancreatic cancer that has spread around his body. According to his doctors, he now has four types of cancer: lymphoma, vascular, lung cancer, liver cancer, and pancreatic cancer.

Speaking to The New York Times’s “Interesting Times” podcast, the Republican Senator from Nebraska reflected on his life and impending death.

Also Read: Encephalitis Alert In Rajasthan As Mystery Disease Claims 2 More Young Lives

Sasse was diagnosed with Stage 4 pancreatic cancer in December 2025, which remained in the shadows for a long time. Until late October, Sasse had no symptoms. But it started with a lot of back and abdominal pain. Initially, he thought it was due to “some ab muscles pulled from stupid forms of training”.

His doctors thought Sasse had some undiagnosed celiac disease or some dairy allergy. However, a full body scan in December revealed that Sasse’s “torso is chock-full of tumors.”

“In mid-December, I got a three- to four-month life expectancy,” he was quoted as saying.

“They told me over the course of the next couple of days that I already have five forms of cancer: lymphoma, vascular, lung cancer, bad liver cancer, and pancreatic, where it originated,” the former senator added. “So, it was pretty clear that we’re dealing with a short number of months left to live.”

Sasse represented Nebraska in the Senate for eight years before resigning to become the president of the University of Florida in July 2024.

During the interview, Sasse said his condition has improved since last December -- his pain is 80 percent reduced.

"I’m at Day 99 or something since then, and I’m doing a heck of a lot better than I was doing at Christmas," he said.

However, the former senator noted that he deals with nausea, as well as bleeding on his face due to intake of the investigational new drug daraxonrasib.

During the interview, the former lawmaker’s face was covered in dried blood.

Death A Wicked Thief, Says Ben Sasse

Sasse, a father of three, said he felt a “heaviness” with respect to realizing he did not have much time left with his family.

“I didn’t like the idea of my 14-year-old son not having a dad around at 16,” he remarked. “I didn’t like the idea of my daughters, who are 22 and 24, not having their dad there to walk them down the aisle. I felt a real heaviness about that.”

However, the Nebraska Republican said he has “continued to feel peace about the fact that death is something that we should hate.”

“We should call it a wicked thief,” he continued. “And yet, it’s pretty good that you pass through the veil of tears one time and then there will be no more tears, there will be no more cancer.”

What Is Pancreatic Cancer? Know The Warning Signs

Pancreatic cancer has long been one of the toughest challenges in oncology. With a five-year survival rate hovering around 13 percent and recurrence rates approaching 80 percent after treatment, the odds have historically been stacked against patients.

The prevention and early detection remain vital.

Experts warn that pancreatic cancer often masquerades as common ailments, delaying diagnosis. Here are some early symptoms that should never be ignored:

• Abdominal or back pain that worsens over time or eases when leaning forward.
• Unexplained weight loss without changes in diet or exercise.
• Jaundice, including yellowing of the eyes and skin, sometimes with intense itching.
• Changes to urine or stool, such as dark urine or pale, greasy stools.
• New-onset diabetes without obvious risk factors.
• Persistent fatigue unrelated to poor sleep or lifestyle

Three simple lifestyle changes, such as regular physical activity, cutting down sedentary time, and improving sleep duration, may significantly boost your brain's cognitive abilities and reduce the risk of dementia later in life, according to a new study.

Dementia is a neurodegenerative condition affecting an estimated 55 million people globally. It is characterized by a decline in memory, thinking, and social abilities.

Together, the three simple lifestyle changes cut down the risk of late-onset dementia by 25 percent.

Published in the open-access journal PLOS One, the systematic review and meta-analysis of over 69 prospective cohort studies involving millions of cognitively healthy adults aged 35 and above showed the potential benefits of lifestyle behaviors such as regular physical activity, cutting down sedentary time, and improving sleep duration.

According to the Alzheimer’s Association, a person’s overall risk for developing Alzheimer’s disease—the most common form of dementia—is about 11 percent. However, the study found that with the simple suggested lifestyle changes, the average person’s risk decreases to approximately 8 percent.

The study emphasized that people do not need elaborate and expensive longevity hacks to stay mentally sharp as they age.

The reduction is “fairly comparable to the effect sizes sometimes seen with medications for chronic diseases,” said Akinkunle Oye-Somefun, a researcher at York University in Toronto, who led the study, NBC News reported.

Sitting For Long Periods Worst For Your Brain

The findings showed that avoiding sitting for longer periods had the greatest effect and can have a long-term benefit for the brain.

Sitting for more than eight hours a day increased dementia risk by almost 30 percent, at the same time being regularly active, even just going for a walk every day, decreased dementia risk by an average of 25 percent.

Long sitting hours can also spike a person’s risk of other conditions such as cardiovascular disease, diabetes, and obesity, all of which in turn raise dementia risk.

Getting between seven and eight hours of sleep each night also had a greater benefit on the brain.

Also read: 'Game Of Thrones' Actor Michael Patrick Dies After Battle With Motor Neurone Disease

The risk of dementia increased by 18 percent among those who slept less than seven hours, while sleeping more than eight hours per night also raised the risk of the neurodegenerative disease by 28 percent.

Importantly, moderate physical activity “offsets dementia risks even when other risk factors are present,” said Oye-Somefun, NBC News reported.

However, “many people assume that being physically active cancels out the harm of sitting for long periods. It doesn’t,” Oye-Somefun said. “We shouldn’t do one of these things alone; we should do them all.”

Also read: Simple Brain Training Exercise Cuts Dementia Risk For 20 Years, Study Finds

What Is Dementia?

Dementia is an umbrella term used to describe a significant decline in mental function that is serious enough to affect everyday life. It commonly impacts memory, thinking, and reasoning skills.

Dementia itself is not a single disease but a collection of symptoms caused by underlying conditions such as Alzheimer’s disease or vascular dementia.

Common signs include

• memory problems,
• confusion,
• difficulty finding words,
• changes in mood or behavior,
• trouble completing familiar tasks.

These symptoms usually worsen over time and are not considered a normal part of ageing. Although there is no cure, treatment options can help manage symptoms, and early diagnosis plays an important role in care planning.